Autoantibodies Prevalence During Checkpoint Inhibitor Treatment

Clinical trial NCT04220034 · COMPLETED

Trial details

NCT number: NCT04220034
Sponsor: CHU de Reims
Status: COMPLETED
Study type: OBSERVATIONAL

Autoimmune Adverse Effects of Anti-neoplasic Drug

Start date: 2020-01-15
Primary completion: 2024-07-22
Enrollment: 183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.